LMVVX
Price
$29.71
Change
-$1.16 (-3.76%)
Updated
Dec 18 closing price
VSIAX
Price
$85.23
Change
-$3.35 (-3.78%)
Updated
Dec 18 closing price
Ad is loading...

LMVVX vs VSIAX

Header iconLMVVX vs VSIAX Comparison
Open Charts LMVVX vs VSIAXBanner chart's image
Lord Abbett Focused Small Cap Value R5
Price$29.71
Change-$1.16 (-3.76%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Value Index Admiral
Price$85.23
Change-$3.35 (-3.78%)
VolumeN/A
CapitalizationN/A
LMVVX vs VSIAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
LMVVX vs. VSIAX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LMVVX is a StrongBuy and VSIAX is a Hold.

FUNDAMENTALS
Fundamentals
VSIAX has more cash in the bank: 63B vs. LMVVX (106M). VSIAX pays higher dividends than LMVVX: VSIAX (2.01) vs LMVVX (0.23). LMVVX was incepted earlier than VSIAX: LMVVX (5 years) vs VSIAX (13 years). LMVVX is a more actively managed with annual turnover of: 54.00 vs. VSIAX (16.00). LMVVX has a lower initial minimum investment than VSIAX: LMVVX (0) vs VSIAX (3000). VSIAX annual gain was more profitable for investors over the last year : 16.23 vs. LMVVX (10.21). VSIAX return over 5 years is better than : 52.83 vs. LMVVX (25.01).
LMVVXVSIAXLMVVX / VSIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence5 years13 years-
Gain YTD8.12615.03154%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets106M63B0%
Annual Yield % from dividends0.232.0112%
Returns for 1 year10.2116.2363%
Returns for 3 years5.6020.6727%
Returns for 5 years25.0152.8347%
Returns for 10 yearsN/A105.65-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALTO1.470.04
+2.80%
Alto Ingredients
ADXN7.80-0.05
-0.64%
Addex Therapeutics Ltd
DCOM33.96-0.84
-2.41%
Dime Community Bancshares
CAVA123.37-3.42
-2.70%
CAVA Group
EWTX30.17-2.52
-7.71%
Edgewise Therapeutics